AMAG PHARMACEUTICALS, INC. - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - February 28, 2018

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - AMAG PHARMACEUTICALS, INC.ex322.htm
EX-32.1 - EXHIBIT 32.1 - AMAG PHARMACEUTICALS, INC.ex321.htm
EX-31.2 - EXHIBIT 31.2 - AMAG PHARMACEUTICALS, INC.ex312.htm
EX-31.1 - EXHIBIT 31.1 - AMAG PHARMACEUTICALS, INC.ex311.htm
EX-23.1 - EXHIBIT 23.1 - AMAG PHARMACEUTICALS, INC.ex231.htm
EX-10.13 - EXHIBIT 10.13 - AMAG PHARMACEUTICALS, INC.ex1013.htm
EX-10.12 - EXHIBIT 10.12 - AMAG PHARMACEUTICALS, INC.ex1012.htm
EX-10.10 - EXHIBIT 10.10 - AMAG PHARMACEUTICALS, INC.ex1010.htm
EX-10.9 - EXHIBIT 10.9 - AMAG PHARMACEUTICALS, INC.ex109.htm
EX-10.8 - EXHIBIT 10.8 - AMAG PHARMACEUTICALS, INC.ex108.htm
EX-10.7 - EXHIBIT 10.7 - AMAG PHARMACEUTICALS, INC.ex107.htm
EX-10.6 - EXHIBIT 10.6 - AMAG PHARMACEUTICALS, INC.ex106.htm
10-K - 10-K - AMAG PHARMACEUTICALS, INC.a201710-k.htm
Exhibit 21.1
AMAG Pharmaceuticals, Inc.
 
Subsidiaries of the registrant


 
AMAG Pharmaceuticals Canada Corporation, a Nova Scotia unlimited liability company
 
AMAG Europe Limited, a UK private limited company
 
AMAG Securities Corporation, a Massachusetts corporation
 
AMAG Pharma USA, Inc., a Delaware corporation
 
FP1096, Inc., a Pennsylvania corporation
  
Drugtech Sárl, a Swiss company
 
Lumara Health Services Ltd., a Missouri corporation

CBR Acquisition Holdings Corp., a Delaware corporation

Cbr Systems, Inc., a Delaware corporation
 
 
 


AMAG PHARMACEUTICALS, INC. Reports